PVT1 and cancer: In the dataset we analysed in [86], all members of the miR-200 family appear to be highly up-regulated in cancer tissues (from 4- to 8- folds) and this up-regulation is counteracted by a similar, even if not comparable, overexpression of PVT1 that in cancer tissues appears to increase of about two folds.